Limited Competition: Clinical and Translational Science Awards (CTSA) Program: Collaborative and Innovative Acceleration Award

The National Institutes of Health (NIH) is announcing a forecast for a Limited Competition under the Clinical and Translational Science Awards (CTSA) Program. The purpose of this program is to accelerate the translation of scientific discoveries into treatments, diagnostics, and health interventions that improve patient and public health. The CTSA Program will support the collaborative development of innovative approaches, technologies, or models that enhance the impact of research, advance translational science, and bring more treatments to people more quickly. Some key points about this opportunity include: • The eligibility for this award is limited to recipients who have successfully competed for an award under the Clinical and Translational Science Awards (CTSA) UM1 NOFO PAR-24-272 or subsequent iterations. • The estimated synopsis posting date is September 1, 2026, and the estimated application response date is February 16, 2027. • The estimated award date is December 15, 2027. • The funding instrument for this award is a Cooperative Agreement.